(Q48326740)

10 February 2018

title

New Approaches for the Treatment of Refractory Meningiomas (English)

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

27 December 2023

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

27 December 2023

author name string

Brian Ragel

1

1 reference

10 February 2018

Randy L. Jensen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12712009

27 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12712009

27 December 2023

publication date

1 March 2003

1 reference

10 February 2018

published in

Cancer Control

1 reference

10 February 2018

volume

10

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

148-158

1 reference

10 February 2018

Expression of estrogen receptors alpha and beta in human meningiomas.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

The recurrence of intracranial meningiomas after surgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Meningioma: analysis of recurrence and progression following neurosurgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Radiotherapy for atypical or malignant intracranial meningioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Treatment of high risk or recurrent meningiomas with hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Occurrence, regulation, and significance of progesterone receptors in human meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Long-term consequences of CNS treatment for childhood cancer, Part I: Pathologic consequences and potential for oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

High incidence of meningioma among Hiroshima atomic bomb survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

21 January 2018

Neurofibromatosis type 2

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Anaplastic and atypical meningiomas express high levels of Fas and undergo apoptosis in response to Fas ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

The role of radiotherapy in the treatment of subtotally resected benign meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Radiation therapy in the treatment of partially resected meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Mifepristone: antineoplastic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Role of antiprogestational therapy for meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Mifepristone (RU 486) treatment of meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Inhibition of the growth of cultured human meningioma cells by recombinant interferon-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

The treatment of malignant meningioma with verotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Successful Treatment of Acromegaly: Metabolic and Clinical Studies in 145 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Cancer and the potential place for growth hormone receptor antagonist therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Inhibitory effect of trapidil on human meningioma cell proliferation via interruption of autocrine growth stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Use of verapamil to enhance the antiproliferative activity of BCNU in human glioma cells: an in vitro and in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Action of calcium antagonists on multidrug resistant cells. Specific cytotoxicity independent of increased cancer drug accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Calcium Channel Blocker Enhancement of Anticancer Drug Cytotoxicity—A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Verapamil increases the sensitivity of primary human colorectal carcinoma tissue to vincristine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Verapamil potentiation of melphalan cytotoxicity and cellular uptake in murine fibrosarcoma and bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Selective intraarterial gene delivery into a canine meningioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Gene therapy for meningioma: improved gene delivery with targeted adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

Interferon-alfa-2b for meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480301000206

21 January 2018

5

33

955

Mahmood A.

1993

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy

27 December 2023

10

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Recent advances in the treatment of skull base tumors using radiation.

27 December 2023

11

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Loss of 1p in recurrent meningiomas. a comparative study in successive recurrences by cytogenetics and fluorescence in situ hybridization

27 December 2023

20

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods

27 December 2023

21

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma

27 December 2023

22

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up

27 December 2023

23

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas

27 December 2023

25

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Prognostic significance of p53 and p21WAF1/CIP1 immunoreactivity and tumor micronecrosis for recurrence of meningiomas

27 December 2023

26

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Apoptotic activity and bcl-2 immunoreactivity in meningiomas. Association with grade and outcome

27 December 2023

27

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Hormonal manipulation of meningiomas in vitro

27 December 2023

35

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo

27 December 2023

36

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice

27 December 2023

37

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

27 December 2023

38

50

2604

Koper J.W.

1990

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B

27 December 2023

44

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Endothelins are angiogenic

27 December 2023

50

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

27 December 2023

Q64786060

57

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop

27 December 2023

61

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Inhibition of in vitro meningioma proliferation after growth factor stimulation by calcium channel antagonists: Part II--Additional growth factors, growth factor receptor immunohistochemistry, and intracellular calcium measurements

27 December 2023

63

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists

27 December 2023

64

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Calcium channel antagonist effect on in vitro meningioma signal transduction pathways after growth factor stimulation

27 December 2023

65

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

Matrigel augments xenograft transplantation of meningioma cells into athymic mice

27 December 2023

67

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

27 December 2023

74

41

1967

Tsuruo T.

1981

1 reference

https://api.crossref.org/works/10.1177/107327480301000206

27 December 2023

Identifiers

1 reference

10 February 2018

1 reference

10 February 2018